BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1279714)

  • 21. Use of CD34+ cell fraction as a measure of hematopoietic stem cells in bone marrow and peripheral blood: comparison with the CFU-GM assay.
    Janssen WE; Lee C; Farmelo MJ; Smilee R; Barth K; Fields KK; Zorsky PE; Elfenbein GJ
    Prog Clin Biol Res; 1992; 377():513-21. PubMed ID: 1279719
    [No Abstract]   [Full Text] [Related]  

  • 22. Positive selection of CD34+ hematopoietic progenitor cells for transplantation.
    Shpall EJ; Jones RB; Bearman SI; Stemmer SM; Purdy MH; Heimfeld S; Berenson RJ
    Stem Cells; 1993 Oct; 11 Suppl 3():48-9. PubMed ID: 7507756
    [No Abstract]   [Full Text] [Related]  

  • 23. [Methods of mobilizing hematopoietic cells, their collection using cell separation, purging--processing of pathologic cells and enrichment with CD 34+ cells--negative and positive selection].
    Walter Z; Szostek M; Mensah P; Lorenz F; Weglarska D; Skotnicki AB
    Przegl Lek; 1999; 56 Suppl 1():22-7. PubMed ID: 10494178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive stem cell selection--basic science.
    Civin CI; Strauss LC; Fackler MJ; Trischmann TM; Wiley JM; Loken MR
    Prog Clin Biol Res; 1990; 333():387-401; discussion 402. PubMed ID: 1689854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Avidin-biotin immunoadsorption for ex vivo bone marrow purging: effect of percentage of target cells and flow rate.
    Lemoli RM; Gobbi M; Tazzari PL; Grassi G; Dinota A; Gherlinzoni F; Mazza P; Tura S
    Haematologica; 1988; 73(3):183-5. PubMed ID: 3139512
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluating efficiency of bone marrow harvest and its manipulation--role of CD 34 positivity.
    Parikh PM; Badrinath Y; Dhond S; Kulkarni S; Dhar AK; Raje N; Saikia TK; Bharbhaya S; Gopal R; Kurkure PA
    J Assoc Physicians India; 1995 Jul; 43(7):470-2. PubMed ID: 8713220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ex vivo expansion of CD34+ hematopoietic progenitors.
    Moore MA; Schneider JG; Shapiro F; Bengala C
    Prog Clin Biol Res; 1994; 389():217-28. PubMed ID: 7535432
    [No Abstract]   [Full Text] [Related]  

  • 28. Peripheral blood stem cell transplantation: from laboratory to clinical practice.
    Mangan KF
    Semin Oncol; 1995 Jun; 22(3):202-9. PubMed ID: 7539938
    [No Abstract]   [Full Text] [Related]  

  • 29. Mature human hematopoietic cells in donor bone marrow complicate interpretation of stem/progenitor cell assays in xenogeneic hematopoietic chimeras.
    Ramírez M; Rottman GA; Shultz LD; Civin CI
    Exp Hematol; 1998 Apr; 26(4):332-44. PubMed ID: 9546317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD34+ progenitor cell selection: clinical transplantation, tumor cell purging, gene therapy, ex vivo expansion, and cord blood processing.
    Colter M; Jones M; Heimfeld S
    J Hematother; 1996 Apr; 5(2):179-84. PubMed ID: 8723797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral blood and positive selection of marrow as a source of stem cells for transplantation.
    Bensinger WI; Berenson RJ
    Prog Clin Biol Res; 1990; 337():93-8. PubMed ID: 1972288
    [No Abstract]   [Full Text] [Related]  

  • 32. Ex-vivo purging of hematopoietic progenitor cells.
    de Lima M; Shpall EJ
    Curr Hematol Rep; 2004 Jul; 3(4):257-64. PubMed ID: 15217555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of marrow purging].
    Rizzoli V; Carlo-Stella C; Mangoni L
    Haematologica; 1991 Jun; 76 Suppl 3():311-20. PubMed ID: 1684346
    [No Abstract]   [Full Text] [Related]  

  • 34. Factors affecting volume reduction and red blood cell depletion of bone marrow on the COBE Spectra cell separator before haematopoietic stem cell transplantation.
    Guttridge MG; Sidders C; Booth-Davey E; Pamphilon D; Watt SM
    Bone Marrow Transplant; 2006 Aug; 38(3):175-81. PubMed ID: 16770313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of human hematopoietic stem cell populations.
    Murray L; DiGiusto D; Chen B; Chen S; Combs J; Conti A; Galy A; Negrin R; Tricot G; Tsukamoto A
    Blood Cells; 1994; 20(2-3):364-9; discussion 369-70. PubMed ID: 7538340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
    Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R
    Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New developments in stem cell detection and stem cell selection in the context of autologous transplantations.
    Douay L; Lopez M; Giarratana MC; Bony V; Bouchet S; Gorin NC
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):87-9. PubMed ID: 8099734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral-blood stem-cell transplantation.
    Med Lett Drugs Ther; 1995 Aug; 37(955):71-2. PubMed ID: 7543181
    [No Abstract]   [Full Text] [Related]  

  • 39. Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors.
    Pilarski LM; Belch AR
    Clin Cancer Res; 2002 Oct; 8(10):3198-204. PubMed ID: 12374689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transplantation of CD34+ hematopoietic progenitor cells.
    Berenson RJ; Shpall EJ; Auditore-Hargreaves K; Heimfeld S; Jacobs C; Krieger MS
    Cancer Invest; 1996; 14(6):589-96. PubMed ID: 8951362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.